Photo taken on June 20, 2017 shows boxes of Heberprot-P, a medication created in 2006 for treating diabetic foot ulcers, at the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, Cuba. Cuba's half a billion-dollar biotechnological industry, considered key to the country's future, is looking to expand with innovation and overseas market development. (Xinhua/Joaquin Hernandez)
